Bcl-2: a brief chronicle
Apoptosis, or programmed cell death, is a genetically controlled process by which appropriate cells are selectively eliminated during development. Deregulation of normal cell death can result in profound, even lethal, consequences. For example, excessive cell death resulting from retinoblastoma gene disruption causes embryonic lethality [l] . Conversely, the suppression of cell death can favour the development and progression of neoplasms [Z] .
Bcl-2 was first identified by virtue of the t( 14; 18) translocation in follicular lymphomas . Transgenic mice constructed to overexpress bcl-2 displayed polyclonal expansion of small resting B-cells in GtJGl of the cell cycle [6] . Most importantly, this hyperplasia did not result from enhanced proliferation, but rather from augmented cell survival. The viability advantage imparted by bcl-2 was determined to be a consequence of the suppression of apoptotic cell death [7] . Progression from indolent hyperplasia to high-grade immunoblastic lymphoma occurred after a latency period of 15 months [8] .
Subsequent to the discovery of bcl-2, a variety of genes capable of regulating cell death have been identified. Many of these genes, including bcl-x, bax, A I , M C L l , bak and bad, exhibit significant sequence similarity with bcl-2, which justifies their inclusion in the bcl-2 gene family. Some bcl-2 family members, such as bcl-X I , and MCL I , function as cell-death suppressors [9- 113. Other bcl-2 homologues, including bax and bak , have powerful death-promoting abilities
Bcl-2 blocks diverse stress signalling pathways
Bcl-2 appears to inhibit multiple cell-death signalling pathways, including those mediated by [7, 20, 21] y and UV radiation [22, 23] , heat shock [24] , p53 [22] , c-Myc [25] , calcium , chemotherapeutic agents [29, 30] , androgen withdrawal [ 3 11, neurotrophin withdrawal [32] and anti-CD3 receptor clustering [33] . These observations prompt two questions. (i) Does a common biochemical denominator exist for these cell-death pathways? (ii) Can Bcl-2 fulfil a cellular role at this level? In this regard, one noticeable common feature of these pathways is that their activation is associated with activation of the sphingomyelin cycle and subsequent events that transpire in the nucleus (Table 1) .
Nuclear alterations associated with apoptosis induction by ROS, UV and *J radiation, adriamycin and daunorubicin include DNA damage. This damage includes oxidation, cleavage, intercalation and thymidine-dimer formation. Following an apoptotic signal, activated ICE degrades nuclear lamins, small nuclear ribonuclear proteins and polyADP-dependent polymerase. T h e tumour suppressor p53 is thought to play a role, in part, as a 'surveyor' of genomic integrity, and in many experimental systems, induction of apoptosis is contingent upon wild-type p53 expression [22] . TNF-(x, UV and y radiation, heat shock and ROS, for their part, also destabilize the inhibitor of nuclear factor (NF)KB, IKBxIMAD-3, by phosphorylation [34-381. The result is reflected in the rapid nuclear accumulation of NFKB.
In addition, many of these apoptotic signals, such as TNF-(x, UV and y radiation, heat shock and peroxides, also elevate intracellular ceramide by activation of the sphingomyelin cycle [39] . Daunorubicin, a commonly used chemotherapeutic drug that induces apoptosis, elevates intracellular ceramide levels through another mechanism involving the activation of ceramide synthase [40] . Interestingly, ceramide has been shown to activate NFKB [41] , thereby providing a link to integrate the sphingomyelin cycle with NFKB-dependent pathways ( Figure 1 ). Since Bcl-2 can suppress apoptosis induced + by these stresses (Table l) , it is reasonable to consider that the ceramide-activated stress pathway may represent a common denominator that may provide insight into the basis of Bcl-2 function.
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Does Bcl-2 moderate the NfKB activation pathway induced by TNF-a?
Because NFKB seems to play a role in mediating multiple stress responses, it is perhaps not surprising that NFKB has been implicated in the regulation of apoptosis [42] . Because Bcl-2 suppresses apoptosis, which is associated with NFKB-mediated stress responses, it is worth considering the relationship between Bcl-2 and NFKB. In many systems phosphorylation of ItiBu proceeds via a protein kinase C-dependent pathway [43] . T h e result is the dissociation and subsequent degradation of ItiB and the rapid nuclear import of activated NFtiB heterodimers (e.g. Re1 A: p65-pSO) [44] . Nuclear NFtiB, in turn, co-operates with other transcription factors, such as Spl, activating transcription factor-2, c-Jun and E26. Interestingly, many common genes implicated in the mediation of apoptotic cell death, including c-myc, ICE and p53, have consensus KB binding sites in their promoters [44] .
Recent evidence suggests that NFKB activation following cell-death induction mediated by Sinbis virus (SV) may be, directly or indirectly, modulated by Bcl-2 [42] . SV-induced apoptosis in this system was also found to be strictly dependent on an NFKB signalling mechanism in that NF KB DNA-binding site 'decoys' (synthetic NFKB-binding site double-stranded oligonucleotides) inhibited SV-induced apoptosis. Intriguingly, Bcl-2 appeared to block the nuclear import of NFKB after challenge with SV.
Bcl-2, however, does not invariably moderate the NFKB activation pathway following cell-death induction. For instance, both bcl-2 and bcl-x were identified in a genetic screen for genes conferring resistance to TNF-a, a strong inducer of NFKB activity, in MCF7 breast adenocarcinoma cells [ 161. Enforced expression of either bcl-2 or bcl-x in MCF7 cells inhibited TNF-a activation of phospholipase A2 (PLA,) but not NFtiB activation. Bcl-2 was also shown to protect against TNF-a-mediated cytotoxicity of L929 cells without interfering with the TNF-a-NF tiB activation pathway [45] . In contrast, direct activation of NFKB by 0.8 mM H202 in L929 cells could be blocked by Bcl-2. These results indicate that regulation of NFKB activation by Bcl-2 function is likely to be context dependent.
Does Bcl-2 moderate the activation of an oxidative stress pathway induced by TNF-a?
If Bcl-2 does not control the pathway(s) leading to NFKB activation and nuclear import, it becomes more difficult to consider its protective function in cells stressed by an NFKB activator.
One possibility is that Bcl-2 might exert its anti death effects by inhibiting the formation of lipid Figure I Pathways for cell stresses leading to the activation of the NFKB and JNK pathways
All the external stresses considered rapidly induce a rise in intracellular cerarnide by activating the sphingornyelin cycle (discussed in the text). Bcl-2 has been shown to protect cells against apoptosis induced by most of these stresses. peroxides [7] . Since lipid peroxides are a favoured substrate for PLA,, it is conceivable that Bcl-2 indirectly influences PLA, activity by buffering lipid peroxidation. Recent evidence suggests that PLA, may be important in the mediation of TNF-a cytotoxicity. First, arachidonic acid is mobilized in TNF-a-sensitive but not -resistant cells [46, 47] . Secondly, inhibitors of PLA, diminish TNF-a cytotoxicity in many cell lines [46] . Lastly, enforced overexpression of PLA, in the TNF-%-resistant subline conveyed a TNF-a-sensitive phenotype [48] .
The emerging ceramide cell stress pathway: a link to Bcl-2?
Sphingolipids play a role in the regulation of cell growth, differentiation, cell-cell contact and oncogenesis [49] . Recently, sphingolipid turnover to ceramide has become recognized as a novel lipid second-messenger signalling pathway initiated by multiple apoptosis signals, including TNF-a, FAS receptor cross-linking, interleukin-1, interferon-y , ligand-unbound low-affinity p75 neurotrophin receptors, vitamin D3, UV, X-radiation, peroxides and heat shock. One factor strongly implicated in transmitting ceramide-mediated stress signalling is the stress-activated protein kinase/Jun kinase (SAPW JNK). Recent evidence suggests that the SAPW JNK pathway is a positively acting pathway for apoptosis following nerve growth factor withdrawal in PC 12 pheochromocytoma cells [50] . Restoration of nuclear growth factor was found to drive the mitogen-activated protein kinase (MAPK) pathway and promote cell survival. Together, the SAPWJNK and MAPK pathway were found to exert opposing effects on cell viability. It may be envisioned that cell viability may be determined, in part, by the net balance or throughput of the MAPK and SAPWJNK pathways. Any signal or combination of signals that selectively activates one pathway would be anticipated to shift the balance in favour of cell survival or cell death.
Ceramide-induced growth inhibition and DNA fragmentation in HL-60 promyelocytic leukaemia cells has also been shown to be contingent upon activator protein 1 activation [51]. Specific anti-sense c-Jun oligonucleotides, but not sense oligonucleotides, diminished ceramide cytotoxicity. Since c-Jun is a target of the highly responsive SAPWJNK cell stress pathway, Verheij et al. [39] examined the effects of ceramide on the activation of SAPWJNK. Apoptosis was induced in human U937 monoblastic leukaemia cells by X-rays, H202, UV-C, heat shock and TNF-a. Each stimulus resulted in a rapid ( e l min) elevation in intracellular ceramide levels with a corresponding decrease in membrane sphingomyelin levels. Importantly, superimposition of a dominant-negative N-terminal deletion mutant of c-Jun or kinase-inactive SAPK kinase-1 mutant into U937 cells blocked apoptosis induced by these stresses but not ceramide immunoprecipitates from C2-ceramide-and TNF-a-stimulated U937 cell extracts revealed robust SAPWJNK activity, as measured by phosphorylation of a c-Jun fusion protein in vim. The MAPK pathway was not activated under these stress conditions. Importantly, other apoptosis signalling pathways, such as cytosine araboniside-and calphostin-C-induced cell-death systems, were unaffected by these genetic manipulations of SAPWJNK, further supporting the specificity of the ceramide pathway.
As with the signals leading to NFKB activation, most of the apoptotic signals mentioned above prompting sphingomyelin hydrolysis are also inhibited by Bcl-2.
Location, location, location
Unlike most proteins that target to a particular organelle or region within the cell, Bcl-2, by virtue of its C-terminal hydrophobic anchor sequence, can be found in three membranous compartments: the mitochondrial membrane, endoplasmic reticulum and nuclear envelope [52, 53] . Interestingly, the intracellular sites of ROS generation are also the mitochondria, endoplasmic reticulum and nucleus. The involvement of Bcl-2 in the regulation of ROS and lipid peroxidation is unclear. However, it has been demonstrated that Bcl-2 can block apoptosis induced by y radiation and TNF-a, two pathways known to involve the generation of ROs Alterations in intracellular Ca2+ are commonly implicated in mediating cell-death signalling events [26- Generation of ceramide by ceramide kinase has also been shown to be calcium dependent [58] . Three sphingomyelinases (SMases) exist that also hydrolyse sphingomyelin to ceramide. The acidic SMase functions optimally at the acidic pH found within the lysosomes. The second SMase also functions at acidic pH but also requires Zn2+ as a cofactor. A neutral SMase that is membrane bound functions at neutral pH and can be activated by TNF-a [59] . It is conceivable that Bcl-2 may reduce ceramide production by inhibiting sphingomyelin hydrolysis, by inhibiting intracellular increases in Ca2+.
Bcl-2 as a gatekeeper regulating transmembrane trafficking
It is known that Bcl-2 preferentially localizes to membrane compartments inside the cell. Electron-microscopic studies have shown that, within the nuclear envelope, Bcl-2 appears to coalesce in a patchy distribution resembling nuclear pores [52, 53] . What role might the nuclear pore complex-targeted Bcl-2 play? One possibility is that nuclear pore complex-associated Bcl-2 may modulate the nuclear-import molecules important for the regulation of cell death. In this regard it is noteworthy that c-Myc and Bcl-2 co-operate to overcome p53-dependent apoptosis by blocking p53 nuclear import at a critical phase in GI of the cell cycle [60] . It has also been reported that the nuclear translocation of the Cdc2 and Cdk2 cyclin A-dependent kinases following a variety of apoptotic stimuli was inhibited by enforced Bcl-2 expression [61] .
Interestingly, Bcl-2 preferentially localizes to sites within the mitochondrial membrane where the inner and outer leaflets are closely approximated. These sites are associated with mitochondrial transmembrane trafficking. It has recently been shown that Bcl-2 can impose a block on the induction of the mitochondrial permeability transition (PT) that accompanies a reduction in the mitochondrial transmembrane potential and correlates with a Bcl-2 mediated impairment of PT-associated apoptosis [62] . How Bcl-2 regulates the P T during apoptotic signals is unclear. Perhaps Bcl-2 interacts directly with the P T pore. Alternatively, Bcl-2 has been reported to enhance oxidative phosphorylation [63] , which might reduce the probability of a P T event.
Bcl-2 has also been shown to inhibit the depletion of Ca2+ stores from the endoplasmic reticulum following cell-death induction by thapsigargin, a selective inhibitor of the endoplasmic reticulum-associated Ca2+ pump [28, 64] . Furthermore, Bcl-2 could also establish a Caz+ gradient across the nuclear envelope following cell-death induction [28] .
Together, these observations suggest that Bcl-2 function may, in part, be a function of selectively regulating the transmembrane trafficking of molecules that are important mediators of cell-death signalling.
I063
Summary
The mechanism by which Bcl-2 can insulate cells against multiple diverse apoptotic signals is largely undefined. How is it possible that Bcl-2, which possesses no known catalytic function, can protect against multiple cell-death signals? A proposal to address this question postulates that Bcl-2 functions at convergence points common to most cell-death signal-transduction pathways. This review attempts to integrate observations regarding cell-death signalling in an effort to define points of convergence. The ceramidel SAPWJNK and NFKB pathways, in particular, were emphasized. Potential points at which Bcl-2 may function frequently involve the transmembrane trafficking of molecules implicated in the mediation of apoptosis. The selectivity of this process and the effector proteins with which Bcl-2 associates remain to be elucidated. 
